Skip to main content

Table 3 Uterotonic drug usage and usage of BCE

From: Bimanual examination for clot evacuation: a retrospective cohort study of women with postpartum haemorrhage after vaginal delivery

 

Total cohort (n = 438)

BCE performed (n = 149)

BCE not performed (n = 289)

p value1

Oxytocin infusion

432 (98.6%)

149 (100%)

283 (97.9%)

0.10

Ergometrine

290 (66.2%)

127 (85.2%)

163 (56.4%)

< 0.001

Ergometrine-additional dose

135 (30.8%)

76 (51.0%)

59 (20.4%)

< 0.001

Misoprostol

186 (42.5%)

93 (62.4%)

93 (32.2%)

< 0.001

PgF2α

10 (2.3%)

8 (5.4%)

2 (0.7%)

0.004

  1. 1Continuous variables were assessed by the t-test and categorical variables were analysed using the chi-squared test. P value of < 0.05 is considered statistically significant